These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2443753)

  • 21. [Acquired myelodysplastic syndromes after treatment of melanoma with fotemustine and dacarbazine].
    Perrot JL; Lanthier K; Benoit F; Graille MC; Guy C; Bertheas MF; Cambazard F
    Ann Dermatol Venereol; 1995; 122(10):663-6. PubMed ID: 8687048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Marked regression of melanoma metastases under combined chemotherapy].
    Klemm-Mayer H; Rasokat H; Wagner G
    Z Hautkr; 1984 Apr; 59(7):443-5. PubMed ID: 6730608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.
    Samson MK; Baker LH; Izbicki RM; Ratanatharathorn V
    Cancer Treat Rep; 1976 Sep; 60(9):1369-71. PubMed ID: 65223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DTIC therapy in metastatic malignant melanoma: a simplified dose schedule.
    Pritchard KI; Quirt IC; Cowan DH; Osoba D; Kutas GJ
    Cancer Treat Rep; 1980; 64(10-11):1123-6. PubMed ID: 7459898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phase II study of decarbazine (DTIC) in malignant melanoma. DTIC Research Group].
    Ishihara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1940-5. PubMed ID: 3707154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dacarbazine in malignant melanoma. Rare, severe side-effect: Budd-Chiari-syndrome (author's transl)].
    Doering C; Pickartz H; Orfanos CE; Altenähr E
    Z Hautkr; 1982 Jul; 57(13):971-80. PubMed ID: 7113323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H; Muth M
    Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583
    [No Abstract]   [Full Text] [Related]  

  • 28. Secondary orbital melanomas: analysis of 15 cases.
    Liarikos S; Rapidis AD; Roumeliotis A; Angelopoulos AP
    J Craniomaxillofac Surg; 2000 Jun; 28(3):148-52. PubMed ID: 10964550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of malignant melanoma with DTIC--therapeutic effects determined by 5-S-cysteinyldopa changes in the urine (proceedings)].
    Agrup G; Hafström L; Jönsson PE; Rorsman H
    Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 364213
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dacarbazin -- therapy of metastazising malignant melanoma (author's transl)].
    Zaumseil RP
    Zentralbl Chir; 1979; 104(15):975-81. PubMed ID: 92112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha.
    Konjević G; Jović V; Radulović S; Jelić S; Dzodić R; Spuzić I
    Neoplasma; 2001; 48(3):175-81. PubMed ID: 11583285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
    Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
    Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adjuvant chemotherapy of malignant melanoma with DTIC. Lack of effect in stage I. Possible improvement of the prognosis for survival in stage IIb].
    Garbe C; Guenther-Eymann K; Stadler R; Orfanos CE
    Hautarzt; 1988 Apr; 39(4):205-12. PubMed ID: 3384660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
    Inoi T; Mojamdar M; Ichihashi M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1982 Sep; 92(10):1065-9. PubMed ID: 6821170
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of malignant melanoma with orbital metastasis which caused the first symptoms].
    Toyoda H; Fukui K; Okabe H; Kitoh A; Iguchi I; Kanematsu I
    No To Shinkei; 1992 Oct; 44(10):929-33. PubMed ID: 1285995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of metastatic malignant melanoma localized to an extremity].
    Jacobsen KD; Tausjø J; Hager B; Gundersen S
    Tidsskr Nor Laegeforen; 2010 Jan; 130(1):21-4. PubMed ID: 20094118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impressive regression of visceral and cerebral melanoma metastases under combination treatment including dacarbacine, radiotherapy and celecoxib.
    Becker MR; Gaiser T
    Int J Dermatol; 2009 Feb; 48(2):207-9. PubMed ID: 19200209
    [No Abstract]   [Full Text] [Related]  

  • 39. Orbital melanoma metastatic from contralateral choroid: management by complete surgical resection.
    Shields JA; Perez N; Shields CL; Singh AD; Eagle RC
    Ophthalmic Surg Lasers; 2002; 33(5):416-20. PubMed ID: 12358296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.
    Frosch PJ; Czarnetzki BM; Macher E; Grundmann E; Gottschalk I
    J Cancer Res Clin Oncol; 1979; 95(3):281-6. PubMed ID: 528568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.